Business
Fangzhou’s ‘XingShi’ LLM Featured by Nature News and Xinhua, Showcasing AI Innovation in Chronic Disease Care
SHANGHAI, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, announced that its “XingShi” Large Language Model (“XS LLM”) was featured by Nature News under the headline “A Chinese AI tool can manage chronic disease — could it revolutionize health care?” The article, written by science reporter Mohana Basu, cited the model’s potential applications for chronic disease management, while citing expert commen
About this update from Fangzhou Inc.
[{"type":"image","alt":"Fangzhou Inc.","displaySize":"","headline":null,"caption":"Fangzhou Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":95,"url":"https://media.zenfs.com/en/globenewswire.com/912b0b077ef808f302b710d614115ef6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/3I4M1onr9I9LGQ_MtZRvAw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEzMztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/912b0b077ef808f302b710d614115ef6","width":300,"height":95}},"lazy":false},{"type":"text","content":"SHANGHAI, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, announced that its “XingShi” Large Language Model (“XS LLM”) was featured by Nature News under the headline “A Chinese AI tool can manage chronic disease — could it revolutionize health care?”","length":371,"tagName":"p"},{"type":"text","content":"The article, written by science reporter Mohana Basu, cited the model’s potential applications for chronic disease management, while citing expert commentary. Xinhua News Agency also highlighted the piece under the headline “Nature focuses on Fangzhou’s XS LLM: Chinese AI tackling global chronic disease challenges.”","length":317,"tagName":"p"},{"type":"text","content":"This recognition underscores the growing role of AI in addressing global health issues. Fangzhou’s XS LLM, released in September, was designed to address ongoing healthcare challenges such as low chronic disease management efficiency, while enabling greater customization of services, and more effective use of physicians’ constrained schedules.","length":345,"tagName":"p"},{"type":"text","content":"“Recognition from Nature demonstrates that Chinese innovation in AI-driven healthcare is earning global attention,” said Fangzhou’s Founder, Chairman and CEO Dr. Xie Fangmin. “With the XS LLM, we aim to provide a scalable, reliable and patient-centered solution that can not only transform chronic disease management in China but also offer insights for healthcare worldwide.”","length":376,"tagName":"p"},{"type":"text","content":"XS LLM integrates multimodal capabilities — image and speech recognition, natural language processing, large-scale medical knowledge storage, and reasoning — while achieving advanced performance benchmarks in medical AI. ...